期刊
FREE RADICAL BIOLOGY AND MEDICINE
卷 60, 期 -, 页码 307-317出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2013.02.021
关键词
Apoptosis; Cardiomyocyte; Coenzyme Q(10); Diabetes; Diastolic function; Fibrosis; Hypertrophy; Inflammation; Superoxide; Free radicals
资金
- Diabetes Australia Research Trust
- National Health and Medical Research Council of Australia (NHMRC) [ID526638]
- Victoria government's Operational Infrastructure Support Program
- Australian Postgraduate Award
- Australian Research Council Future Fellowship [FT0001757]
- NHMRC [586604, ID472673, ID1043026]
Cardiac oxidative stress is an early event associated with diabetic cardiomyopathy, triggered by hyperglycemia. We tested the hypothesis that targeting left-ventricular (LV) reactive oxygen species (ROS) upregulation subsequent to hyperglycemia attenuates type 1 diabetes-induced LV remodeling and dysfunction, accompanied by attenuated proinflammatory markers and cardiomyocyte apoptosis. Male 6-week-old mice received either streptozotocin (55 mg/kg/day for 5 days), to induce type 1 diabetes, or citrate buffer vehicle. After 4 weeks of hyperglycemia, the mice were allocated to coenzyme Q(10) supplementation (10 mg/kg/day), treatment with the angiotensin-converting-enzyme inhibitor (ACE-I) ramipril (3 mg/kg/day), treatment with olive oil vehicle, or no treatment for 8 weeks. Type 1 diabetes upregulated LV NADPH oxidase (Nox2, p22(phox), p47(phox) and superoxide production), LV uncoupling protein UCP3 expression, and both LV and systemic oxidative stress (LV 3-nitrotyrosine and plasma lipid peroxidation). All of these were significantly attenuated by coenzyme Q(10). Coenzyme Q(10) substantially limited type 1 diabetes-induced impairments in LV diastolic function (E:A ratio and deceleration time by echocardiography, LV end-diastolic pressure, and LV -dP/dt by micromanometry), LV remodeling (cardiomyocyte hypertrophy, cardiac fibrosis, apoptosis), and LV expression of proinflammatory mediators (tumor necrosis factor-alpha, with a similar trend for interleukin IL-1 beta). Coenzyme Q(10's) actions were independent of glycemic control, body mass, and blood pressure. Coenzyme Q(10) compared favorably to improvements observed with ramipril. In summary, these data suggest that coenzyme Q(10) effectively targets LV ROS upregulation to limit type 1 diabetic cardiomyopathy. Coenzyme Q(10) supplementation may thus represent an effective alternative to ACE-Is for the treatment of cardiac complications in type 1 diabetic patients. (C) 2013 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据